Anne Holck Storås is an oncologist with primary interest in urological cancer. She works part time, 50%, at the Norwegian Cancer Registry. Her project is a register based study of health related outcomes after introduction of new anti-cancer drugs in patients with metastatic prostate cancer.
Anne Holck Storås is a medical doctor, graduated from university of Oslo and is a specialist in oncology. She defended her thesis «Adverse effects after curative treatment for prostate cancer; an international perspective» in 2017. She works 50% as a consultant in Department of Oncology.
“Health outcomes and prognostic factors after introduction of new anti-cancer drugs in patients with metastatic prostate cancer: A population-based study”
Utvalgte publikasjoner/Lenker/sosiale medier/medieklipp:
1: Ávila M, Patel L, López S, Cortés-Sanabria L, Garin O, Pont À, Ferrer F,
Boladeras A, Zamora V, Fosså S, Storås AH, Sanda M, Serra-Sutton V, Ferrer M.
Patient-reported outcomes after treatment for clinically localized prostate
cancer: A systematic review and meta-analysis. Cancer Treat Rev. 2018
May;66:23-44. doi: 10.1016/j.ctrv.2018.03.005. Epub 2018 Apr 3. Review. PubMed
2: Fosså SD, Storås AH, Steinsvik EA, Myklebust TA, Eri LM, Loge JH, Dahl AA.
Psychometric testing of the Norwegian version of the Expanded Prostate Cancer
Index Composite 26-item version (EPIC-26). Scand J Urol. 2016 Aug;50(4):280-5.
doi: 10.3109/21681805.2016.1163617. Epub 2016 Apr 6. PubMed PMID: 27049891.
3: Storås AH, Sanda MG, Boronat OG, Chang P, Patil D, Crociani C, Suarez JF,
Cvancarova M, Loge JH, Fosså SD. Erectile Dysfunction and Sexual Problems Two to
Three Years After Prostatectomy Among American, Norwegian, and Spanish Patients.
Clin Genitourin Cancer. 2016 Jun;14(3):e265-73. doi: 10.1016/j.clgc.2015.10.009.
Epub 2015 Oct 26. PubMed PMID: 26778476.
4: Storås AH, Sanda MG, Ferrer M, Loge JH, Dahl AA, Steinsvik EA, Guedea F,
Cvancarova M, Fosså SD. Localized prostate cancer in Norway, the United States,
and Spain: between-country differences of variables before treatment among
patients eligible for curative treatment. Clin Genitourin Cancer. 2014
Aug;12(4):e117-25. doi: 10.1016/j.clgc.2013.12.007. Epub 2014 Jan 3. PubMed PMID:
24524968; PubMed Central PMCID: PMC5021779.